Your browser doesn't support javascript.
loading
Inotuzumab ozogamicin in B-cell precursor acute lymphoblastic leukemia: efficacy, toxicity, and practical considerations.
Rubinstein, Jeremy D; O'Brien, Maureen M.
Affiliation
  • Rubinstein JD; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
  • O'Brien MM; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Front Immunol ; 14: 1237738, 2023.
Article in En | MEDLINE | ID: mdl-37600823
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Aged / Child / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Burkitt Lymphoma / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Aged / Child / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication: